5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.45▲ | 1.44▲ | 1.45▲ | 1.41▲ | 1.28▲ |
MA10 | 1.45▲ | 1.44▲ | 1.45▲ | 1.34▲ | 1.37▲ |
MA20 | 1.44▲ | 1.45▲ | 1.44▲ | 1.28▲ | 1.38▲ |
MA50 | 1.44▲ | 1.42▲ | 1.38▲ | 1.38▲ | 2.59▼ |
MA100 | 1.45▲ | 1.37▲ | 1.28▲ | 1.39▲ | 2.83▼ |
MA200 | 1.44▲ | 1.28▲ | 1.29▲ | 2.27▼ | 2.48▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.003▼ | -0.004▼ | 0.034▲ | 0.075▲ |
RSI | 60.839▲ | 55.479▲ | 59.383▲ | 60.244▲ | 41.105▼ |
STOCH | 91.667▲ | 35.723 | 28.175 | 79.639 | 26.490 |
WILL %R | 0.000▲ | -61.538 | -38.095 | -12.195▲ | -39.496 |
CCI | 108.982▲ | 16.721 | 47.887 | 109.790▲ | 17.375 |
▲ GAP | $GERN Open Gap Up %2 | Set Alert |
Thursday, August 14, 2025 02:26 PM
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney ...
|
Friday, August 08, 2025 01:14 PM
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted an equity award in the form of stock options to purchase 11,000,000 shares of common ...
|
Friday, August 08, 2025 06:30 AM
GERN reported underlying demand growth of 17% for Rytelo in Q2 vs. Q1 and increased use in early lines of therapy. Click here to find out why GERN is a Buy.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.48 | 1.50 | 1.42 | 1.45 | 12,196,223 |
14/08/25 | 1.40 | 1.475 | 1.38 | 1.45 | 7,675,098 |
13/08/25 | 1.37 | 1.465 | 1.34 | 1.43 | 17,152,991 |
12/08/25 | 1.38 | 1.405 | 1.31 | 1.35 | 8,767,187 |
11/08/25 | 1.32 | 1.41 | 1.31 | 1.36 | 15,175,372 |
08/08/25 | 1.29 | 1.33 | 1.26 | 1.28 | 11,324,357 |
07/08/25 | 1.42 | 1.43 | 1.29 | 1.30 | 14,193,778 |
06/08/25 | 1.30 | 1.39 | 1.28 | 1.39 | 28,417,677 |
05/08/25 | 1.22 | 1.24 | 1.19 | 1.20 | 8,560,756 |
04/08/25 | 1.17 | 1.23 | 1.1603 | 1.21 | 13,974,395 |
|
|
||||
|
|
||||
|
|